Situation normale

OMEGA PHARMA INNOVATION & DEVELOPMENT
 SA

9050 Gent
Since 09/10/2006
BE0884084724
Financial Health Indicator
9
Equity
€228.9M
+84% YoY
Operating Income
€212.9M
+267% YoY
EBITDA
€174.0M
+727% YoY
Gain/Loss
€175.2M
+1698% YoY
Employees
44
+2% YoY

OMEGA PHARMA INNOVATION & DEVELOPMENT’s business network visualized

Explore our interactive spiderweb to visually navigate OMEGA PHARMA INNOVATION & DEVELOPMENT’s entire network of mandates and participations. Get insights into both current and historical connections.

Spiderweb OMEGA PHARMA INNOVATION & DEVELOPMENT
OMEGA PHARMA INNOVATION & DEVELOPMENT
  • SONIA HOLLIES
  • Anja van Winsberghe
    8980 Zonnebeke
    Since 2021
  • Magali Verbraeken
    9840 Nazareth-De Pinte
    Since 2023

Detailed insights into OMEGA PHARMA INNOVATION & DEVELOPMENT’s financial history

See financial trends including, equity, operating income, profit/loss and employees of OMEGA PHARMA INNOVATION & DEVELOPMENT. Compare KPI’s against similar companies. Explore financial ratios, annual accounts and much more.

Financials 1
Financials 2
Financials 3
Financials 4
2024 2023 2022 2021 2020
Equity
228.9M
124.6M
123.4M
121.4M
274.8M
Operating Income
212.9M
57.9M
49.8M
45.4M
44.6M
Gain/Loss
175.2M
9.7M
2.0M
-9.9M
-186.1M
Employees
44
43
48
45
47

Frequently asked questions about OMEGA PHARMA INNOVATION & DEVELOPMENT

  • Where is OMEGA PHARMA INNOVATION & DEVELOPMENT located?

    OMEGA PHARMA INNOVATION & DEVELOPMENT’s headquarters is located in Gaston Crommenlaan 6 606, 9050 Gent.
  • Who are the directors of OMEGA PHARMA INNOVATION & DEVELOPMENT?

    OMEGA PHARMA INNOVATION & DEVELOPMENT’s directors include
    • SONIA HOLLIES
    • Anja van Winsberghe
    • Magali Verbraeken
  • When was OMEGA PHARMA INNOVATION & DEVELOPMENT founded?

    OMEGA PHARMA INNOVATION & DEVELOPMENT was founded in 2006-10-09. OMEGA PHARMA INNOVATION & DEVELOPMENT has been active for 19 years.
  • What are OMEGA PHARMA INNOVATION & DEVELOPMENT’s NACEBEL codes?

    OMEGA PHARMA INNOVATION & DEVELOPMENT’s NACEBEL codes are
    • 72101 Recherche-développement en biotechnologie (2025)
    • 72109 Recherche-développement en autres sciences physiques et naturelles (2025)
    • 72110 Recherche-développement en biotechnologie (2008)
    • 72190 Recherche-développement en autres sciences physiques et naturelles (2008)
    • 73100 Recherche et développement en sciences physiques et naturelles (2003)
  • What is OMEGA PHARMA INNOVATION & DEVELOPMENT’s VAT number?

    OMEGA PHARMA INNOVATION & DEVELOPMENT’s VAT number is BE0884084724.
  • What is OMEGA PHARMA INNOVATION & DEVELOPMENT’s juridical form?

    OMEGA PHARMA INNOVATION & DEVELOPMENT’s juridical type is Société anonyme (SA).
  • How many employees does OMEGA PHARMA INNOVATION & DEVELOPMENT have?

    OMEGA PHARMA INNOVATION & DEVELOPMENT has 44 employees.
  • How is the financial situation of OMEGA PHARMA INNOVATION & DEVELOPMENT?

    openthebox has estimated that OMEGA PHARMA INNOVATION & DEVELOPMENT’s financial health score to be 9/10.